XML 65 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2014
Earnings Per Share [Abstract]  
Summary of Computation of Basic and Diluted Net Loss Per Share

The following table summarizes the computation of basic and diluted net loss per share attributable to the Company’s common stockholders:

 

    Three months ended March 31,  
              2014                         2013            

Net Income/(loss)

  $ 412      $ (2,069

Deemed dividend for beneficial conversion feature on Series D-2 Preferred

    (909     —     

Deemed dividend for antidilution adjustments to convertible preferred stock

    (214     —     

Accretion of convertible preferred stock

    (510     —     
 

 

 

   

 

 

 

Net loss attributable to common stock - basic

  $ (1,221   $ (2,069

Derivative fair value adjustment

    (2,783     —     
 

 

 

   

 

 

 

Net loss attributable to common stock - diluted

  $ (4,004   $ (2,069
 

 

 

   

 

 

 

Weighted-average common shares outstanding - basic

    334,086        335,782   

Allocation of common stock warrants as participating securities

    274,988        —     
 

 

 

   

 

 

 

Weighted-average of outstanding common stock - diluted

    609,075        335,782   
 

 

 

   

 

 

 

Net loss per share

   

Basic EPS

  $ (3.65   $ (6.16

Diluted EPS

  $ (6.57   $ (6.16
Summary of Antidilutive Securities Excluded from Computation of Weighted Average Common Stock Outstanding

The following securities, presented on a common stock equivalent basis, have been excluded from the calculation of weighted average common shares outstanding because the effect is anti-dilutive:

 

     Three Months Ended
March 31,
 
     2014      2013  

Convertible preferred stock:

     

Series A Preferred

     6,149         6,149   

Series B Preferred

     131,685         93,568   

Series C Preferred

     783,515         554,181   

Series C-2 Preferred

     173,213         119,958   

Series D-1 Preferred

     296,773         —     

Series D-2 Preferred

     300,549         —     

Warrants to purchase Series C-1 Preferred

     14,033         9,847   

Warrants to purchase common stock

     —           26,603   

Stock options

     184,240         152,464   

Convertible notes

     —           430,493